7CO1 image
Deposition Date 2020-08-03
Release Date 2020-11-25
Last Version Date 2023-11-29
Entry Detail
PDB ID:
7CO1
Title:
Crystal structure of SMAD2 in complex with wild-type CBP
Biological Source:
Source Organism:
Homo sapiens (Taxon ID: 9606)
Host Organism:
Method Details:
Experimental Method:
Resolution:
3.30 Å
R-Value Free:
0.28
R-Value Work:
0.25
R-Value Observed:
0.25
Space Group:
P 21 21 21
Macromolecular Entities
Structures with similar UniProt ID
Protein Blast
Polymer Type:polypeptide(L)
Molecule:Mothers against decapentaplegic homolog 2
Gene (Uniprot):SMAD2
Mutagens:S465E, S467E
Chain IDs:A, C, E
Chain Length:208
Number of Molecules:3
Biological Source:Homo sapiens
Structures with similar UniProt ID
Protein Blast
Polymer Type:polypeptide(L)
Molecule:CREB-binding protein
Gene (Uniprot):CREBBP
Chain IDs:B, D, F
Chain Length:28
Number of Molecules:3
Biological Source:Homo sapiens
Ligand Molecules
Primary Citation
Structural basis for transcriptional coactivator recognition by SMAD2 in TGF-beta signaling.
Sci.Signal. 13 ? ? (2020)
PMID: 33323411 DOI: 10.1126/scisignal.abb9043

Abstact

Transforming growth factor-β (TGF-β) proteins regulate multiple cellular functions, including cell proliferation, apoptosis, and extracellular matrix formation. The dysregulation of TGF-β signaling causes diseases such as cancer and fibrosis, and therefore, understanding the biochemical basis of TGF-β signal transduction is important for elucidating pathogenic mechanisms in these diseases. SMAD proteins are transcription factors that mediate TGF-β signaling-dependent gene expression. The transcriptional coactivator CBP directly interacts with the MH2 domains of SMAD2 to activate SMAD complex-dependent gene expression. Here, we report the structural basis for CBP recognition by SMAD2. The crystal structures of the SMAD2 MH2 domain in complex with the SMAD2-binding region of CBP showed that CBP forms an amphiphilic helix on the hydrophobic surface of SMAD2. The expression of a mutated CBP peptide that showed increased SMAD2 binding repressed SMAD2-dependent gene expression in response to TGF-β signaling in cultured cells. Disrupting the interaction between SMAD2 and CBP may therefore be a promising strategy for suppressing SMAD-dependent gene expression.

Legend

Protein

Chemical

Disease

Primary Citation of related structures